REF#533

This well-established, multi-location specialty pharmacy group presents a rare opportunity to acquire a high-performing healthcare business in the rapidly growing pharmaceutical and infusion services sector. Operating across several prime locations in Texas, the company provides prescription dispensing, specialty medications, compounded drugs, and infusion therapies, supported by strong relationships with pharmacy benefit managers and healthcare providers.

The business generates approximately $60M in trailing twelve-month revenue (Feb 2025- Feb 2026) with ~8.4M EBITDA, reflecting strong cash flow and improving operational performance. Profitability has significantly increased through a strategic shift toward higher-margin product lines, including generics, compounded medications, and GLP-1 therapies.

With an experienced team of over 100 employees and scalable infrastructure already in place, this operation is positioned for continued growth and efficiency. The diversified payor mix and lack of customer concentration further enhance stability and reduce risk.

Ideal for strategic buyers, investors, or healthcare operators seeking immediate cash flow, scale, and expansion opportunities, this turnkey platform offers both stability and significant upside potential in a high-demand, recession-resistant healthcare segment.

Inquire Today!
Fill out our contact form for more information! (check spam)
REF#533

WE ALSO PROVIDE FINANCING

Best Regards,
ProMed Financial, Inc.

*Disclaimer, for confidentiality purposes, the advertisement image is not the practice being sold.